Review
the MET gene for the treatment of non-small-cell
This review will focus on the MET pathway and its role in resistance to EGFR TK (tyrosine kinase) inhibitors, the different strategies of its inhibition, and the potential approaches to overcoming acquired resistance.
F. Gelsomino, F. Facchinetti, E. Haspinger et al.
· 0 citations